Drug Information

Drug General Information
Drug ID
D0O9OW
Former ID
DNC013772
Drug Name
N-isobutylnorlitebamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534555]
Formula
C23H27NO4
Canonical SMILES
CC(C)CN1CCC2=C(C1)C(=C(C3=C2C=CC4=CC(=C(C=C43)OC)O)OC)O
InChI
1S/C23H27NO4/c1-13(2)11-24-8-7-15-16-6-5-14-9-19(25)20(27-3)10-17(14)21(16)23(28-4)22(26)18(15)12-24/h5-6,9-10,13,25-26H,7-8,11-12H2,1-4H3
InChIKey
WKTMDLQZTZEUIG-UHFFFAOYSA-N
PubChem Compound ID
10643561
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [534555]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 534555J Nat Prod. 1998 Jan;61(1):46-50.Litebamine N-homologues: preparation and anti-acetylcholinesterase activity.
Ref 534555J Nat Prod. 1998 Jan;61(1):46-50.Litebamine N-homologues: preparation and anti-acetylcholinesterase activity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.